BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Short Interest Update

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) was the recipient of a significant decrease in short interest in the month of January. As of January 31st, there was short interest totalling 1,900 shares, a decrease of 61.2% from the January 15th total of 4,900 shares. Based on an average daily trading volume, of 129,600 shares, the days-to-cover ratio is currently 0.0 days.

BriaCell Therapeutics Stock Performance

Shares of NASDAQ:BCTXW traded down $0.02 during mid-day trading on Thursday, reaching $0.11. The stock had a trading volume of 33,750 shares, compared to its average volume of 109,290. The firm has a 50 day simple moving average of $0.24 and a two-hundred day simple moving average of $0.27. BriaCell Therapeutics has a twelve month low of $0.08 and a twelve month high of $1.89.

BriaCell Therapeutics Company Profile

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.